We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+6.89%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$9.83B
AUM Growth
+$1.07B
(+12%)
Cap. Flow
-$195M
Cap. Flow
% of AUM
-1.98%
Top 10 Holdings %
Top 10 Hldgs %
25.87%
Holding
1,420
New
446
Increased
141
Reduced
120
Closed
281
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDFC Bank
HDB
|
+$63.2M |
| 2 |
Microsoft
MSFT
|
+$58.5M |
| 3 |
GSK
GSK
|
+$50.8M |
| 4 |
Infosys
INFY
|
+$49.3M |
| 5 |
Amphenol
APH
|
+$46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Truist Financial
TFC
|
+$61.3M |
| 2 |
Northern Trust
NTRS
|
+$59.7M |
| 3 |
NVIDIA
NVDA
|
+$58M |
| 4 |
Credit Acceptance
CACC
|
+$53.9M |
| 5 |
BHP
BHP
|
+$45.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.1% |
| 2 | Healthcare | 3.88% |
| 3 | Consumer Staples | 2.93% |
| 4 | Energy | 2.82% |
| 5 | Financials | 2.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Alcoa
AA
$11.7B
| – | – |
-425,656
| Closed | -$14.5M |
|
1102
Apple
AAPL
$4.92T
| – | – |
-69,070
| Closed | -$12.6M |
|
1103
Abbott
ABT
$183B
| – | – |
-66,722
| Closed | -$7.65M |
|
1104
AerCap
AER
$23.9B
| – | – |
-355,605
| Closed | -$26.4M |
|
|
AFMD
1105
DELISTED
Affimed
AFMD
| – | – |
-5,136
| Closed | -$32.1K |
|
1106
Allstate
ALL
$67.3B
| – | – |
-203,308
| Closed | -$28.5M |
|
1107
Altimmune
ALT
$568M
| – | – |
-25,000
| Closed | -$281K |
|
1108
Alvotech Warrant
ALVOW
$45.3M
| – | – |
-350,629
| Closed | -$877K |
|
|
APLS
1109
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-46,700
| Closed | -$2.8M |
|
|
APLS
1110
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-114,069
| Closed | -$6.83M |
|
1111
Applovin
APP
$138B
| – | – |
-52,582
| Closed | -$2.1M |
|
1112
Appian
APPN
$1.92B
| – | – |
-125,000
| Closed | -$4.71M |
|
1113
CALL
argenx
ARGX
$56.2B
| – | – |
-6,200
| Closed | -$2.36M |
|
|
1114
argenx
ARGX
$56.2B
| – | – |
-1,100
| Closed | -$418K |
|
1115
PUT
ARK Innovation ETF
ARKK
$5.69B
| – | – |
-150,000
| Closed | -$7.86M |
|
|
CVSA
1116
Covista Inc
CVSA
$4.08B
| – | – |
-3,543
| Closed | -$209K |
|
1117
ATI
ATI
$25.9B
| – | – |
-7,200
| Closed | -$327K |
|
1118
PUT
Anavex Life Sciences
AVXL
$234M
| – | – |
-25,000
| Closed | -$233K |
|
1119
Alibaba
BABA
$273B
| – | – |
-211,823
| Closed | -$15.5M |
|
1120
Bank of America
BAC
$435B
| – | – |
-423,147
| Closed | -$14.5M |
|
1121
CALL
BridgeBio Pharma
BBIO
$16.5B
| – | – |
-25,000
| Closed | -$1.01M |
|
1122
Bio-Rad Laboratories Class A
BIO
$8.56B
| – | – |
-2,506
| Closed | -$809K |
|
1123
Baker Hughes
BKR
$60.2B
| – | – |
-571,137
| Closed | -$19.5M |
|
|
BPMC
1124
PUT
DELISTED
Blueprint Medicines
BPMC
| – | – |
-2,600
| Closed | -$240K |
|
1125
Peabody Energy
BTU
$2.77B
| – | – |
-258,040
| Closed | -$6.28M |
|
Similar funds
AS
TI
LMR Partners's Q1 2024 Portfolio in Review
As of Q1 2024, LMR Partners held 1,420 positions worth $9.83B, up 12% from $8.76B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
LMR Partners's Q1 2024 filing shows 446 new, 141 increased, 120 reduced and 281 closed positions. Its largest new stake was GSK: 1,232,283 shares worth $52.8M. The largest sale was Truist Financial, an estimated $61.3M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 5.9% a quarter earlier, followed by Healthcare and Consumer Staples.
- LMR Partners's largest Q1 2024 buy was GSK: 1,232,283 shares worth $52.8M.
- LMR Partners added most to HDFC Bank in Q1 2024, an estimated $63.2M increase.
- LMR Partners's biggest Q1 2024 reduction was Credit Acceptance, cutting an estimated $53.9M.
- LMR Partners fully exited Truist Financial in Q1 2024, selling an estimated $61.3M.
- LMR Partners's ten largest holdings make up 26% of its $9.83B portfolio in Q1 2024.
- LMR Partners opened 446 new positions and closed 281 in Q1 2024.
- LMR Partners's portfolio value rose 12% quarter-over-quarter to $9.83B.
Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.